Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent Thalassemia Patients: A Preliminary Study
Keywords:
Thalassemia, Transfusion Independence, Thalidomide, Safety and EfficacyAbstract
Background: Thalidomide is known to have hypnosedative, immuno-modulatory and anti-angiogenic effects. The drug is widely used in several neoplastic disorders, inflammatory conditions and skin disorders. Thalidomide has been successfully used in limited number of adult thalassemia patients. Studies on younger thalassemia patients are lacking.
Objective: Current study aims at exploring efficacy and safety profile of thalidomide in younger thalassemia patients.
Methods: A cohort of 20 randomly selected transfusion dependent thalassemia patients were enrolled into the study. Base-line clinico-haematological and biochemical parameters were recorded for each patient. All the patients were given thalidomide for a period of six months and the response was recorded on monthly basis. Data collected was analysed for statistical significance. Study patients included 16 male and 4 female patients.
Results: Mean age of study patients was 12.8 ± 3.6 years. Mean haemoglobin (Hb) levels, pre and post thalidomide, were 4.8 (±1.5) g/dL and 8.2 (±1.8) g/dL respectively (p-value <0.05). Among study patients, 8 (40%) showed Excellent Response, 7 (35%) showed Good Response, 3 (15%) had Poor Response while 2 (10%) patients did not respond to the treatment. No major side effects of therapy were observed among study patients.
Conclusion: The study concludes that thalidomide significantly raises Hb levels in transfusion dependent thalassemia patients when given in low doses. Safety profile for usage of thalidomide in this group of patients is satisfactory.
Trial Registration: NCT03651102, https://clinicaltrials.gov/ct2/show/NCT03651102
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Muhammad Tariq Masood Khan; Inayat ur Rahman, Hamidullah Shah, Munawar Ali Shah, Muhammad Tariq Humayun Khan, Sami Ullah Shakir, Imran Khan, Abid Sohail Taj
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
